Laurus Labs IPO Details

Issue Open Dec 6, 2016
Issue Close Dec 8, 2016
IPO Price ₹428
Face Value ₹10
IPO Size ₹1,331.80 Cr
Listing At BSE, NSE
IPO Lot Size 35
  1. Macrotech lists at 10% discount to IPO price

    Mon, 19 Apr 2021 19:09:00 GMT

    Macrotech Developers, formerly Lodha Developers, made a weak debut on the bourses with the stock listing at ?439, a 10% discount to its issue price of ?486. The stock ended at ?463 per share on BSE.

  2. Aditya Birla Sun Life AMC files papers with Sebi for IPO

    Mon, 19 Apr 2021 21:52:00 GMT

    Aditya Birla Capital has approved sale of up to 28,50,880 equity shares of face value of Rs 5 each held in ABSLAMC out of the total paid-up share capital of 28,80,00,000 equity shares of Aditya Birla ...

  3. Laurus Labs’ Stock Hits A Record High On New Bullish Analyst Coverage

    Wed, 07 Apr 2021 00:38:00 GMT

    Shares of Laurus Labs Ltd. jumped to a record high after Antique Stock Broking initiated coverage on the drugmaker with a ‘buy’ rating, saying that it has entered a new growth phase, backed by ...

  4. Glenmark Life Sciences files IPO papers with SEBI; plans to sell over 73 lakh shares via OFS

    Sat, 17 Apr 2021 01:31:00 GMT

    The IPO will be subject to market conditions ... Glenmark Life Sciences will join the likes of Divis Laboratories Ltd, Laurus Labs Ltd, Shilpa medicare Ltd, Aarti Drugs Ltd and Solara Active ...

  5. Laurus Labs expects revenue generation to begin in FY18

    Mon, 19 Dec 2016 01:22:00 GMT

    A collection of the most-viewed Moneycontrol videos.

  6. Laurus Labs shares decline over 4 pc after promoters offload total 1.3 pc shareholding

    Fri, 05 Mar 2021 09:13:00 GMT

    New Delhi, Mar 5 () Shares of Laurus Labs Ltd on Friday declined over four per cent after two promoters offloaded shares of the company. On BSE, the scrip ended at Rs 351.3, down 4.63 per cent ...

  7. Stock Market Highlights: Sensex rallies 460 points, Nifty ends above 14,800 after RBI policy; banks, auto stocks lead

    Wed, 07 Apr 2021 03:02:00 GMT

    Indian benchmark indices, Sensex and Nifty ended higher Wednesday led across the board gains after the RBI kept policy rates unchanged but committed to a massive government bond purchase programme.

  8. Elevation Capital-Think Investments blank cheque firm files for US listing

    Mon, 22 Mar 2021 06:43:00 GMT

    This allows those looking to go public skip the traditional IPO and list on the bourse with less regulatory ... and public investments in Bajaj Finance, Laurus Labs and Radico Khaitan.

  9. public offer

    Fri, 02 Apr 2021 17:00:00 GMT

    Another 22 companies have lined up IPO plans in 2016 bringing the year-end estimated total deal value to USD 5.8 billion.

  10. Glenmark Life Sciences files IPO papers with SEBI; plans to sell over 73 lakh shares via OFS

    Sat, 17 Apr 2021 00:20:40 GMT

    Glenmark Life Sciences Ltd, a subsidiary of Glenmark Pharmaceuticals Ltd, filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator SEBI for its IPO ...

  11. Glenmark Life Sciences files IPO papers with SEBI; plans to sell over 73 lakh shares via OFS

    Sat, 17 Apr 2021 05:50:00 GMT

    Glenmark Life Sciences Ltd, a subsidiary of Glenmark Pharmaceuticals Ltd, filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator SEBI for its IPO China refuses to vacate ...

Laurus Labs IPO Alerts

1. Laurus Labs Ltd IPO - Listing  Friday, December 16, 2016 7:47:13 AM

Laurus Labs IPO Listing Date

› Listing Date: Monday, December 19, 2016
› BSE Script Code: 540222
› NSE Symbol: LAURUSLABS
› Listing In: ‘B’ Group of Securities
› ISIN: INE947Q01010
› Issue Price: Rs. 428.00 Per Equity Share
› Face Value: Rs. 10.00 Per Equity Share

2. Laurus Labs Ltd IPO - Allotment  Thursday, December 15, 2016 7:40:07 AM

Laurus Labs Ltd IPO Allotment Status is now available online.

Laurus Labs Ltd is Hyderabad based pharmaceutical company engaged in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

The Initial Public Offer of Laurus Labs subscribed 4.53 times (1.58 times in retail). Public Issue of Laurus Labs was closed for subscription on Dec 08, 2016.

3. Laurus Labs Ltd IPO - Close  Tuesday, December 6, 2016 8:06:53 AM

Laurus Labs Ltd IPO to open on Dec 06, 2016 and close for subscription on Dec 08, 2016. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level. The equity shares of the company to be list at BSE and NSE.

4. Lauras Labs Ltd IPO - Open  Tuesday, December 6, 2016 8:06:38 AM

Laurus Labs Ltd is entering in the capital markets with an initial public offering, Fresh Issue aggregating up to Rs 300.00 Cr and Offer for Sale of 24,107,440 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 426 at lower level and Rs 428 at upper level.

Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

The issue opens on Dec 06, 2016 and closes for subscription on Dec 08, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Laurus Labs IPO News & Events FAQs

  1. 1. When Laurus Labs IPO expected date?

    The Laurus Labs IPO is proposed to open on Dec 6, 2016. The IPO application ends on Dec 8, 2016.

  2. 2. How to purchase Laurus Labs IPO?

    Retail investors can apply in the retail or non-institutional investor category from Dec 6, 2016 to Dec 8, 2016. The Laurus Labs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When Laurus Labs IPO will come?

    The Laurus Labs IPO will open for subscription on Dec 6, 2016. The public issue will close on Dec 8, 2016.









Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App